Drug Shortage Report for MOUNJARO
| Report ID | 210464 |
| Drug Identification Number | 02541106 |
| Brand name | MOUNJARO |
| Common or Proper name | tirzepatide injection |
| Company Name | ELI LILLY CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | |
| Strength(s) | 15MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 3 mL single-dose vial |
| ATC code | A10BX |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-12-03 |
| Actual start date | 2023-12-04 |
| Estimated end date | 2024-12-02 |
| Actual end date | 2024-12-02 |
| Shortage status | Resolved |
| Updated date | 2024-12-03 |
| Company comments | For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2024-12-03 | French | Compare |
| v14 | 2024-12-03 | English | Compare |
| v13 | 2024-08-30 | French | Compare |
| v12 | 2024-08-30 | English | Compare |
| v11 | 2024-05-09 | French | Compare |
| v10 | 2024-05-09 | English | Compare |
| v9 | 2024-02-22 | French | Compare |
| v8 | 2024-02-22 | English | Compare |
| v7 | 2024-02-02 | French | Compare |
| v6 | 2024-02-02 | English | Compare |
| v5 | 2023-12-05 | French | Compare |
| v4 | 2023-12-05 | English | Compare |
| v3 | 2023-12-04 | English | Compare |
| v2 | 2023-11-17 | French | Compare |
| v1 | 2023-11-17 | English | Compare |
Showing 1 to 15 of 15